Company: CMND
Filing Date: 2025-09-19
Form Type: F-1
Source: 0001213900-25-089545
Chunk: 28

Company: Clearmind Medicine Inc.
Filing Date: 2025-09-19
Form: F-1
Chunk 28
---
 of our issued and outstanding common shares. Except where otherwise indicated, all share and per share data
in this prospectus have been retroactively restated to reflect the aforementioned consolidations.

Authorized Share Capital

As of September 18, 2025, we had
5,466,441 common shares issued and outstanding and our authorized share capital consists of an unlimited number of common shares, no
par value.

In the last three years, we
have issued an aggregate of 1,961,194 common shares for aggregate net proceeds of $19.6 million net of share issuance costs in several
public offerings and private placements. In addition, during the same period, 1,999,687 warrants were exercised for gross proceeds of
$5.2 million.

In addition to common shares,
in the last three years, we have granted (i) share options to employees, directors, consultants and service providers under our Executive
Stock Option and Restricted Share Unit Plans exercisable into an aggregate of 1,222,959 common shares, with exercise prices ranging from
$23.40 to $651.10 per share; and (ii) an aggregate of 4,335,758 warrants exercisable into common shares, with exercise prices ranging
from $1.0777 to $243.75 per share, which were issued in three private placements.

Common Shares

All of our common shares are
one and the same class, identical in all respects and have equal rights, powers and privileges.

Voting.Except as otherwise
provided for by resolution of our Board, the holders of outstanding common shares have the exclusive right to vote on all matters requiring
shareholder action. On each matter on which holders of common shares are entitled to vote, each outstanding share of common share is entitled
to one vote.

Dividends.Holders
of our common shares have equal rights of participation in the dividends and other distributions of our cash, stock or property when,
as and if declared thereon by our Board from time to time out of our assets or funds legally available therefor and shall have equal rights
to receive our assets and funds available for distribution to shareholders in the event of any liquidation, dissolution or winding up
of our affairs, whether voluntary or involuntary.

Liquidation.Holders
of our common shares have equal rights to receive our assets and funds available for distribution to shareholders in the event of any
liquidation, dissolution or winding up of our affairs, whether voluntary or involuntary.

Rights and Preferences.
Holders of